A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Gaining Popularity Online
The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors market the drug there before redirecting buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Experts Express Worries
However, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in users injecting substances of uncertain source.
Some professionals said the demand for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate medicines, advertising, and consumer laws, potentially leading to fines, legal action or prison.
Service Response and Material Elimination
Based on the social media company, the platform has taken down violative content and prohibited related hashtags and query recommendations. The organization stated it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, filled with photos of weight loss, positive testimonials and step-by-step guides for mixing or administering at home.
Within minutes of entering one group, a seller shared WhatsApp details, where the majority of transactions occur. The seller sent an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.
Product Details and Pricing
Within these groups, messages show black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service stated it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they can’t verify. Although the science behind this drug is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has already seen individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose users to possibly serious health risks”.
